Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.970
+0.030 (1.02%)
At close: Jun 27, 2025, 4:00 PM
3.000
+0.030 (1.01%)
After-hours: Jun 27, 2025, 5:40 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $40.74 million as of June 27, 2025. Its market cap has increased by 33.45% in one year.
Market Cap
40.74M
Enterprise Value
18.61M
1-Year Change
33.45%
Ranking
Category
Stock Price
2.97
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $40.74M, a decrease of -53.28%. That is a compound annual growth rate of -5.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.53B |
| Johnson & Johnson | 366.59B |
| AbbVie | 331.01B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 276.00B |
| Abbott Laboratories | 232.11B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |